Donor stem cells used at licensed Thai facilities are safe from communicable diseases. This is due to strict Advanced Therapy Medicinal Product (ATMP) regulations. Certified laboratories conduct intensive screening for HIV, Hepatitis B, Hepatitis C, and syphilis. Safety relies on choosing clinics that provide verified donor screening records and sterile lab certificates.
- Regulatory framework: The Thai Ministry of Health classifies stem cells as medicinal products requiring sterility validation.
- Infectious disease panels: Labs use molecular testing to eliminate tissues carrying viruses, bacteria, or toxins.
- Certified processing: The Demarest Clinic uses AABB-accredited processes for culturing and activating mesenchymal stem cells.
- Safety documentation: Patients should request a Certificate of Analysis (COA) to confirm batch-specific viral screening.
Bookimed Expert Insight: Australian patients find security at clinics like Intrarat Hospital. Specialists there, such as Dr Thongchai Theerajumyaporn, maintain Melbourne-based training in stem cell therapy. This connection to Australian clinical standards provides a familiar benchmark for safety protocols. It also helps bridge the gap between international regulations and local expectations.
Patient Consensus: Patients recommend asking for the exact source of donor cells. They also suggest requesting written proof of infectious disease screening. They advise confirming that the lab is accredited and always asking for batch traceability documents before starting treatment.